Literature DB >> 32875355

Cellular prion protein dysfunction in a prototypical inherited metabolic myopathy.

Sophie Mouillet-Richard1, Fatima Djouadi2, Fatima-Zohra Boufroura3, Céline Tomkiewicz-Raulet4, Virginie Poindessous3, Johan Castille5, Jean-Luc Vilotte5, Jean Bastin3.   

Abstract

Inherited fatty acid oxidation diseases in their mild forms often present as metabolic myopathies. Carnitine Palmitoyl Transferase 2 (CPT2) deficiency, one such prototypical disorder is associated with compromised myotube differentiation. Here, we show that CPT2-deficient myotubes exhibit defects in focal adhesions and redox balance, exemplified by increased SOD2 expression. We document unprecedented alterations in the cellular prion protein PrPC, which directly arise from the failure in CPT2 enzymatic activity. We also demonstrate that the loss of PrPC function in normal myotubes recapitulates the defects in focal adhesion, redox balance and differentiation hallmarks monitored in CPT2-deficient cells. These results are further corroborated by studies performed in muscles from Prnp-/- mice. Altogether, our results unveil a molecular scenario, whereby PrPC dysfunction governed by faulty CPT2 activity may drive aberrant focal adhesion turnover and hinder proper myotube differentiation. Our study adds a novel facet to the involvement of PrPC in diverse physiopathological situations.

Entities:  

Keywords:  Cellular prion protein; Focal adhesions; Inherited fatty acid oxidation disorders; Inherited metabolic myopathy; Muscle differentiation; Redox balance

Year:  2020        PMID: 32875355     DOI: 10.1007/s00018-020-03624-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  30 in total

1.  Neuritogenesis: the prion protein controls β1 integrin signaling activity.

Authors:  Damien Loubet; Caroline Dakowski; Mathéa Pietri; Elodie Pradines; Sophie Bernard; Jacques Callebert; Hector Ardila-Osorio; Sophie Mouillet-Richard; Jean-Marie Launay; Odile Kellermann; Benoit Schneider
Journal:  FASEB J       Date:  2011-10-28       Impact factor: 5.191

2.  Regulation of focal adhesion formation and filopodia extension by the cellular prion protein (PrPC).

Authors:  Yvonne Schrock; Gonzalo P Solis; Claudia A O Stuermer
Journal:  FEBS Lett       Date:  2008-12-29       Impact factor: 4.124

Review 3.  Metabolic myopathies: clinical features and diagnostic approach.

Authors:  Edward C Smith; Areeg El-Gharbawy; Dwight D Koeberl
Journal:  Rheum Dis Clin North Am       Date:  2011-05       Impact factor: 2.670

Review 4.  Focal adhesion kinase and its role in skeletal muscle.

Authors:  Zachary A Graham; Philip M Gallagher; Christopher P Cardozo
Journal:  J Muscle Res Cell Motil       Date:  2015-07-04       Impact factor: 2.698

5.  Biosynthesis, processing, and extracellular release of alpha-L-fucosidase in lymphoid cell lines of different genetic origins.

Authors:  R A DiCioccio; K S Brown
Journal:  Biochem Genet       Date:  1988-06       Impact factor: 1.890

Review 6.  Prions: protein aggregation and infectious diseases.

Authors:  Adriano Aguzzi; Anna Maria Calella
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

7.  Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins.

Authors:  D Westaway; S J DeArmond; J Cayetano-Canlas; D Groth; D Foster; S L Yang; M Torchia; G A Carlson; S B Prusiner
Journal:  Cell       Date:  1994-01-14       Impact factor: 41.582

8.  A new AMPK activator, GSK773, corrects fatty acid oxidation and differentiation defect in CPT2-deficient myotubes.

Authors:  Fatima-Zohra Boufroura; Carole Le Bachelier; Céline Tomkiewicz-Raulet; Dimitri Schlemmer; Jean-François Benoist; Pascal Grondin; Yann Lamotte; Olivier Mirguet; Sophie Mouillet-Richard; Jean Bastin; Fatima Djouadi
Journal:  Hum Mol Genet       Date:  2018-10-01       Impact factor: 6.150

9.  Inducible overexpression of wild-type prion protein in the muscles leads to a primary myopathy in transgenic mice.

Authors:  Shenghai Huang; Jingjing Liang; Mengjie Zheng; Xinyi Li; Meiling Wang; Ping Wang; Difernando Vanegas; Di Wu; Bikram Chakraborty; Arthur P Hays; Ken Chen; Shu G Chen; Stephanie Booth; Mark Cohen; Pierluigi Gambetti; Qingzhong Kong
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-09       Impact factor: 11.205

10.  Activation of p53-regulated pro-apoptotic signaling pathways in PrP-mediated myopathy.

Authors:  Jingjing Liang; Debra Parchaliuk; Sarah Medina; Garrett Sorensen; Laura Landry; Shenghai Huang; Meiling Wang; Qingzhong Kong; Stephanie A Booth
Journal:  BMC Genomics       Date:  2009-04-28       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.